logo

MRNA

Moderna·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

MRNA fundamentals

Moderna (MRNA) released its earnings on Nov 6, 2025: revenue was 1.02B (YoY -45.22%), beat estimates; EPS was -0.51 (YoY -1800.00%), beat estimates.
Revenue / YoY
1.02B
-45.22%
EPS / YoY
-0.51
-1800.00%
Report date
Nov 6, 2025
MRNA Earnings Call Summary for Q3,2025
  • Revenue Resilience: U.S. COVID vaccine sales down 20%-40% YoY, but mNEXSPIKE captures 55% of volume. International partnerships (Canada, U.K., Australia) to drive future growth.
  • Cost Efficiency: $900 million in 2025 cash savings, targeting $4.6 billion in cash costs. Year-end cash projected at $6.5 billion-$7 billion.
  • Pipeline Momentum: mRNA 1010 flu vaccine and mRNA 1083 combo filings expected by Jan 2026. IntiSPOTRAN oncology program advancing with Merck. Rare disease programs (PA, MMA) nearing registration.
  • Strategic Focus: Postponing large phase 3 trials until 2028 cash break-even. Focusing on high ROI oncology and rare disease investments.
EPS
Revenue

Revenue & Expenses

MRNA has released its 2025 Q3 earnings report, with revenue of 1.02B, reflecting a YoY change of -45.44%, and net profit of -200.00M, showing a YoY change of -1638.46%. The Sankey diagram below clearly presents MRNA's revenue sources and cost distribution.

Key Indicators

Moderna (MRNA) key financial stats and ratios, covering profitability, financial health, and leverage.
Moderna (MRNA)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Moderna (MRNA)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Moderna (MRNA)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Moderna (MRNA) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Moderna (MRNA) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield